...
首页> 外文期刊>Biochemical and Biophysical Research Communications >MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13
【24h】

MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13

机译:MiR-126-5p通过抑制MMP-13调节巨细胞瘤中的破骨细胞分化和骨吸收

获取原文
获取原文并翻译 | 示例

摘要

Giant cell tumor (GCT) of bone is an aggressive skeletal tumor characterized by localized bone resorption. Matrix metalloproteinase-13 (MMP-13) is the principal proteinase expressed by the stromal cells of GCT (GCTSCs) and also considered to play a crucial role in formation of the osteolytic lesion in GCT. However, the exact mechanism of the regulation of MMP-13 expression in GCTSCs was unknown. In this study, we identified miR-126-5p was significantly downregulated in GCTSCs and affect osteoclast (OC) differentiation and bone resorption by repressing MMP-13 expression at the post-transcriptional level. Thus, our studies show that miR-126-5p plays an important physiological role in multinucleated giant cell formation and osteolytic lesion in GCT.
机译:骨骼的巨细胞瘤(GCT)是一种以局部骨吸收为特征的侵袭性骨骼肿瘤。基质金属蛋白酶-13(MMP-13)是GCT基质细胞(GCTSCs)表达的主要蛋白酶,也被认为在GCT溶骨性病变的形成中起着至关重要的作用。但是,尚不清楚调控MGC-13表达的确切机制。在这项研究中,我们发现miR-126-5p在GCTSC中显着下调,并通过在转录后水平上抑制MMP-13表达来影响破骨细胞(OC)的分化和骨吸收。因此,我们的研究表明,miR-126-5p在GCT中的多核巨细胞形成和溶骨性病变中起着重要的生理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号